AusperBio Highlights Major Advances in AHB-137 Clinical Development

SAN FRANCISCO, July 5, 2024 /PRNewswire/ — AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure for chronic…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks